Solubility and chemistry of materials encountered by beryllium mine and ore extraction workers: Relation to risk

Journal of Occupational and Environmental Medicine

Volumn 53, Issue 10, 2011, Pages 1187-1193

  Deubner, David C ^a   Sabey, Philip ^a   Huang, Wenjie ^b,c   Fernandez, Diego ^b   Rudd, Abigail ^b   Johnson, William P ^b   Storrs, Jason ^d,e   Larson, Rod ^d  

^a Alloy Customer Technical Service Department   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c University of Utah   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e Dade Moeller and Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOY; ALUMINUM; BERYLLIUM; BERYLLIUM SULFATE; SILICON;

ARTICLE; BERYLLIOSIS; BIOCHEMICAL COMPOSITION; CONCENTRATION PROCESS; CONTROLLED STUDY; DISEASE SURVEILLANCE; HUMAN; HUMAN CELL; LUNG FLUID; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MINER; MINING; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PH MEASUREMENT; SENSITIZATION; SOLUTION AND SOLUBILITY; SURFACE PROPERTY;

EID: 80054034117     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31822cfe38     Document Type: Article

References (22)

1. Deubner DC, Kelsh M, Shun M, Maier L, Kent M, Lau E. Beryllium sensitization, chronic beryllium disease and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg. 2001;16:579-592. (Pubitemid 32428741)
2. Kreiss K, Mroz MM, Zhen B, Wiedeman H, Barna B. Risks of beryllium disease related to work processes at a metal, alloy and oxide plant. Occup Environ Med. 1997;54:605-612. (Pubitemid 27374989)
3. HuangW, FernandezD, Rudd A, et al.Dissolution and nanoparticle generation behavior of Be-associated materials in synthetic lung fluid using inductively coupled plasma mass spectroscopy and flow field-flow fractionation. J Chromatogr A. 2011;1218:4149-4159.
4. KreissK,MrozMM,Newman LS,Martyny J, Zhen B. Machining risk of beryllium disease and sensitizationwith median exposures below 2 micrograms/m3. Am J Indust Med. 1996;30:16-25. (Pubitemid 26279451)
5. Henneberger PK, Cumroe D, Deubner DC, Kent MS,McCawleyM, Kreiss K. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health. 2001;74:167-176. (Pubitemid 32377453)
6. Schuler CR, Kent MS, Deubner DC, et al. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med. 2005;47:195-205. (Pubitemid 40326251)
7. Schuler CR, Kitt MM, Henneberger PK, Deubner DC, Kreiss K. Cumulative sensitization and disease in a beryllium oxide ceramics worker cohort. J Occup Environ Med. 2008;50:1343-1350.
8. Stefaniak AB, Chipera SJ, Day GA, et al. Physiochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: Implications for risk assessment. J Toxicol Environ Health A. 2008;71:1468-1481.
9. Thomas CA, Bailey RL, Deubner DC, Kreiss K, Schuler CR. Preventive program reduces beryllium sensitization among new employees at a copperberyllium alloy facility. Public Health Rep. 2009;124:112-124.
10. Cummings EJ, Deubner DC, Day GA, et al. Enhanced preventive program at a beryllium oxide ceramics facility reduces beryllium sensitization among new workers. Occup Environ Med. 2007;64:134-140.
11. Taiwo OA, Slade MD, Cantley LF, et al. Beryllium sensitization in aluminum smelter workers. J Occup Environ Med. 2008;50:157-162. (Pubitemid 351321683)
12. Taiwo OA, SladeMD, Cantley LF, Kirshe SR,Wesdock JC, CullerMR. Prevalence of beryllium sensitization among aluminum smelterworkers. OccupMed (Lond). 2010;60:569-571.
13. Curtis GH. Cutaneous hypersensitivity due to beryllium; a study of thirteen cases. AMA Arch Derm Syphilol. 1951;64:470-482.
14. Wegner R, Heinrich-Ramm R, Nowak D, Olma K, Poschadel B, Szadkowski B. Lung function, biological monitoring and biological effect monitoring of gemstone cutters exposed to beryls. Occ Environ Med. 2000;57:133-139. (Pubitemid 30265458)
15. Muller-Quernheim J, Gaede KI, Fireman E, Zissel G. Diagnosis of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J. 2006;27:1190-1195. (Pubitemid 44914303)
16. Exley C, Siesjo P, Eriksson H. The immunobiology of aluminum adjuvants: How do they really work? Trends Immunol. 2010;31:103-172.
17. Brewer JM. (How) do aluminum adjuvants work? Immunol Lett. 2006;102: 10-15.
18. Clarke S. A novel enzyme-linked immunosorbent assay (ELISA) for the detection of beryllium antibodies. J Immunol Methods. 1991;137:65-72.
19. Clarke S, Thurlow SM, Hilmas DE. Application of beryllium antibodies in risk assessment and health surveillance: Two case studies. Toxicol Ind Health. 1995;11:399-411.
20. American Conference of Governmental Industrial Hygienists. Beryllium and compounds: TLV chemical substances. In: Documentation of the Threshold Limit Values and Biological Exposure Indices, 7th Ed. Cincinnati, OH: American Conference of Governmental Industrial Hygienists; 2001.
21. Kelleher PC, Martyny JW, Mroz MM, et al. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med. 2001;43:238-249. (Pubitemid 32238503)
22. Kent MS, Robins TG, Madl AK. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility. Appl Occup Environ Hyg. 2001;6:539-558. (Pubitemid 32428738)